Serum neurofilament light chain in early relapsing remitting MS is increased and correlates with CSF levels and with MRI measures of disease severity

Serum neurofilament light chain levels are increased in patients with a clinically isolated syndrome

(2015) Giulio Disanto et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

The prognostic value of CSF neurofilaments in multiple sclerosis at 15-year follow-up

(2015) A. Petzold   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Neurofilament light chain: A prognostic biomarker in amyotrophic lateral sclerosis

(2015) C.-H. Lu et al.   NEUROLOGY

Fingolimod and CSF neurofilament light chain levels in relapsing-remitting multiple sclerosis

(2015) J. Kuhle et al.   NEUROLOGY

An evaluation of volume-based morphometry for prediction of mild cognitive impairment and Alzheimer's disease

(2015) Daniel Schmitter et al.   NeuroImage-Clinical

CSF Neurofilament Light Chain but not FLT3 Ligand Discriminates Parkinsonian Disorders

(2015) Megan K. Herbert et al.   Frontiers in Neurology

Assessing tissue damage in multiple sclerosis: a biomarker approach

(2014) J. Burman et al.   ACTA NEUROLOGICA SCANDINAVICA

Cerebrospinal fluid immunological biomarkers associated with axonal damage in multiple sclerosis

(2014) L. M. Villar et al.   EUROPEAN JOURNAL OF NEUROLOGY

Multicontrastconnectometry: A new tool to assess cerebellum alterations in early relapsing-remitting multiple sclerosis

(2014) David Romascano et al.   HUMAN BRAIN MAPPING

Serum neurofilament light chain is a biomarker of human spinal cord injury severity and outcome

(2014) J. Kuhle et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Myelin and iron concentration in the human brain: A quantitative study of MRI contrast

(2014) Carsten Stüber et al.   NEUROIMAGE

Natalizumab in progressive MS: Results of an open-label, phase 2A, proof-of-concept trial

(2014) J. Romme Christensen et al.   NEUROLOGY

Advanced MRI unravels the nature of tissue alterations in early multiple sclerosis

(2014) Guillaume Bonnier et al.   Annals of Clinical and Translational Neurology

Cerebrospinal fluid neurofilament concentration reflects disease severity in frontotemporal degeneration

(2013) Carole S. Scherling et al.   ANNALS OF NEUROLOGY

A comparative study of CSF neurofilament light and heavy chain protein in MS

(2013) Jens Kuhle et al.   Multiple Sclerosis Journal

Micro-Structural Brain Alterations in Aviremic HIV+ Patients with Minor Neurocognitive Disorders: A Multi-Contrast Study at High Field

(2013) Cristina Granziera et al.   PLoS One

Increased Neurofilament Light Chain Blood Levels in Neurodegenerative Neurological Diseases

(2013) Johanna Gaiottino et al.   PLoS One

Relationship between Cerebrospinal Fluid Biomarkers for Inflammation, Demyelination and Neurodegeneration in Acute Optic Neuritis

(2013) Signe Modvig et al.   PLoS One

CSF inflammation and axonal damage are increased and correlate in progressive multiple sclerosis

(2012) Jeppe Romme Christensen et al.   Multiple Sclerosis Journal

CSF neurofilament and N-acetylaspartate related brain changes in clinically isolated syndrome

(2012) M Khalil et al.   Multiple Sclerosis Journal

Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria

(2011) Chris H. Polman et al.   ANNALS OF NEUROLOGY

Axonal damage in the making: Neurofilament phosphorylation, proton mobility and magnetisation transfer in multiple sclerosis normal appearing white matter

(2011) A. Petzold et al.   EXPERIMENTAL NEUROLOGY

Axonal damage in relapsing multiple sclerosis is markedly reduced by natalizumab

(2010) Martin Gunnarsson et al.   ANNALS OF NEUROLOGY

Neurofilament light as a prognostic marker in multiple sclerosis

(2010) Jonatan Salzer et al.   Multiple Sclerosis Journal

Combination of CSF N-acetylaspartate and neurofilaments in multiple sclerosis

(2009) C. E. Teunissen et al.   NEUROLOGY